One study reported that lower plasma IGF-1 levels in patients with HCC correlated with poor overall survival.[19] Even though the mechanism of sarcopenia is multifactorial, it might imply that lower IGF-1 and severe sarcopenia may be reflected in poor liver function and higher mortality. This evidence concerns the gene IGF1 and hepatocellular carcinoma.